LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.

Source:http://linkedlifedata.com/resource/pubmed/id/20111888

Download in:

View as

General Info

PMID
20111888